Trial of immunopotentiation by levamisole in patients with pulmonary tuberculosis.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D007958:Leukocyte Count; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D011897:Random Allocation; D012882:Skin Tests; D013601:T-Lymphocytes / Q000276:immunology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D000995:Antitubercular Agents; D007978:Levamisole